Akoya Biosciences
Quanterix to Acquire Akoya Biosciences
The deal will integrate Akoya's spatial biology capabilities with Quanterix's biomarker-detection tools for ultra-sensitive detection of protein biomarkers in blood and tissue.
The past year was difficult for many life science tools companies but not all doom and gloom for some single-cell and spatial omics firms.
Akoya Biosciences Licenses Early-Stage Melanoma Test From NeraCare
The exclusive license agreement builds on an existing research collaboration between the companies to develop assays for skin cancer using Akoya's immunofluorescence platform.
GenomeWeb Top 40 Rises 3 Percent in November Amidst Mixed Broader Market
In comparison, the Dow Jones Industrial Average rose 8 percent and the Nasdaq rose 6 percent, but the Nasdaq Biotech Index was in negative territory, falling by less than 1 percent.
Akoya Biosciences Stock Slumps Following Disappointing Q3 Results
The spatial biology firm lowered its 2024 guidance for the third consecutive quarter and said it is considering strategic alternatives for its business.